Second-line treatment feasible for advanced pancreatic cancer

Second-line therapy is supported for patients with metastatic pancreatic cancer, with fluoropyrimidine-containing regimens providing substantial benefits.
Source: MedWire News - Category: Consumer Health News Tags: Oncology Source Type: news